I am a genitourinary medical oncologist with a particular focus on recurrent and advanced prostate cancer. I conduct clinical and translational studies to bring new therapies to patients with prostate cancer. In particular, I am interested in developing novel androgen-directed therapies, genetically-targeted therapies, and immunotherapies for men with recurrent or advanced prostate cancer, and using germline and tumor genomics to inform precision oncology approaches for these patients. I also have an interest in liquid biomarker development, including the clinical validation of the AR-V7 marker as well as DNA repair markers and their therapeutic implications. I am also involved in mentoring fellows and junior faculty in the clinical care of genitourinary cancers and the development of translational research strategies related to prostate cancer.

Emmanuel Antonarakis

University of Minnesota, Minnesota

Topic: PROpel: A Phase 3 Trial of LYNPARZA + Abi/Pred as Initial Therapy in Patients With mCRPC